Home/Filings/4/0001140361-23-001504
4//SEC Filing

Benton Susan 4

Accession 0001140361-23-001504

CIK 0001228627other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 5:28 PM ET

Size

5.0 KB

Accession

0001140361-23-001504

Insider Transaction Report

Form 4
Period: 2023-01-11
Benton Susan
Director
Transactions
  • Award

    Common Stock

    2023-01-11+16,26767,433 total
Footnotes (1)
  • [F1]The Reporting Person was granted shares of common stock in lieu of cash for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $3.07 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 11, 2023.

Documents

1 file

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001373649

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:28 PM ET
Size
5.0 KB